KRISTIN DALY: Open Payments
NPI 1275951147 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,669 in 28 payments from 19 companies in 2025. Trend: 2023 $3,515 · 2024 $2,281 · 2025 $2,669
Food & beverage: $2,037Consulting: $536Education: $95
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $536 |
| Daiichi Sankyo Inc. | 6 | $489 |
| AstraZeneca Pharmaceuticals LP | 2 | $189 |
| Gilead Sciences, Inc. | 2 | $142 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $131 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| BTG International Inc. | 1 | $125 |
| Incyte Corporation | 1 | $122 |
| Exelixis Inc. | 1 | $121 |
| Astellas Pharma US Inc | 1 | $118 |
Products named: VECTIBIX, DATROWAY, Trodelvy, ZYNLONTA, LYNOZYFIC, VORAXAZE, Zynyz, CABOMETYX.
Industry payments across MO — which companies pay providers there.
